iGlarLixi as a First Injectable: Simplifying Real-World Clinical Practice – DiaObeCon 2026
Dr. Sudhir Bhandari participated in the Learning from Legends session at DiaObeCon 2026 - Annual Conference of Diabetes & Obesity in Ahmedabad on 19 September 2026. His session, scheduled from 5:05 PM to 5:25 PM, focused on iGlarLixi as a First Injectable: Simplifying Real-World Clinical Practice.


